Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

are depressant drugs used to treat anxiety, panic attacks and sleep disorders, among other conditions. “If you take benzodiazepines for a long period of time, it can cause dementia,” Hasan said.

Largest ever protein study set to revolutionise cancer and dementia tests - Tens of millions of pounds in investment is being ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...

Not only has medical journal The Lancet added two new risk factors for the condition (high LDL cholesterol and vision loss), but dementia-slowing drugs donanemab and lecanemab were approved for ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...